Live
Home·Deals·Biotechnology·XTL Biopharmaceuticals acquires NeuroNOS Ltd.
SEO URLwww.firestrike.ai/deals/neuronos-ltd-xtl-biopharmaceuticals-acquisition-2026
acquisitionAnnounced · Jan 13, 2026BiotechnologySource · CredibleArticle · Factual
NeuroNOS Ltd.
XTL Biopharmaceuticals
NeuroNOS Ltd. · XTL Biopharmaceuticals

XTL Biopharmaceuticals acquires NeuroNOS Ltd.

David Najork
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
ShareXLinkedInEmail
Deal value
$33.5M
Target
NeuroNOS Ltd.
NeuroNOS Ltd.
NASDAQ: XAIR
Acquirer
XTL Biopharmaceuticals
XTL Biopharmaceuticals
Full Acquisition
Status
Announced

XTL Biopharmaceuticals agreed to acquire NeuroNOS Ltd.. Reported deal value: $33.5M. Status: Announced. Sector: Biotechnology. Target headquarters context: Location not specified.

This page summarizes publicly available information about the transaction as of 2026-01-13. Figures and status may change as filings and press coverage update.

XTL Biopharmaceuticals Ltd

Deal timeline

Announced
Jan 13, 2026 · globenewswire.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in Biotechnology with a reported deal value of $33.5M. Figures and status may change as sources update.

Sources: globenewswire.com · Primary article · FireStrike proprietary index